期刊文献+

瘦素、胰岛素样生长因子-1与多囊卵巢综合征高胰岛素血症的关系 被引量:3

The Relationship Between Leptin, Insulin-like Growth Factor-1 (IGF-1) and Hyperinsulinemia of Patients with Polycystic Ovarian Syndrome
下载PDF
导出
摘要 目的了解瘦素、胰岛素样生长因子-1(IGF-1)与多囊卵巢综合征(PCOS)高胰岛素血症间的关系,探讨相关发病机制。方法采用病例-对照的方法,实验分为PCOS组(92例)和对照组(92例),其中PCOS组又分为PCOS-高胰岛素血症组(46例)和PCOS-非高胰岛素血症组(46例)。通过放免法检测血清瘦素、胰岛素样生长因子-1、睾酮、双氢睾酮、脱氢表雄酮、硫酸脱氢表雄酮等的水平,葡萄糖氧化酶法检测血糖水平。结果PCOS组瘦素(16.8±9.8ng/mL)、IGF-1水平(214.8±131.6ng/mL)明显高于对照组(分别为11.6±6.8ng/mL、118.0±82.9ng/mL)(P<0.05)。PCOS患者中高胰岛素组瘦素水平(19.2±10.2ng/mL)明显高于正常胰岛素组(12.5±7.6ng/mL)(P<0.05),IGF-1及空腹血糖在两组间差异无统计学意义。多元逻辑回归结果显示,在调整了体重指数、睾酮、黄体生成素/卵泡刺激素比值、双氢睾酮、脱氢表雄酮、硫酸脱氢表雄酮等因素后,瘦素、IGF-1均是PCOS的危险因素,但均不是高胰岛素血症的危险因素。结论瘦素、IGF-1可能与PCOS的发病机制有关,但与高胰岛素血症的关系有待进一步探讨。 Objective To identify the effect of IGF-1 and leptin on the hyperinsulinemia (HI) of patients with polycystic ovarian syndrome (PCOS). Methods The case-control compared method was applied to the study. Ninety-two PCOS and 92 control subjects were involved in the study. The group of PCOS was further divided into two subgroups of 46 PCOS-HI and 46 PCOS-NHI. The leptin, IGF-1 and other hormones such as serum testosterone, DHT, DHEA, DHEA-S were measured by RIA method. Results Leptin and IGF-1 were higher in PCOS group (16.8±9.8 ng/mL, 214.8±131.6 ng/mL) than those in control group (11.6± 6.8 ng/ mL, 118. 0±82.9 ng/mL respectively, P〈0. 05). Serum leptin level was higher in hyperinsulinemia group (9.2± 10.2 ng/mL) than that in normal insulin group (12. 5±7.6 ng/mL,P〈0. 05). IGF-1 (208. 7±109.7 ng/mL vs. 151.7±120. 0 ng/mL, P=0. 66)and fasting glucose (5.1±0. 5 mmol/L vs. 4.9±0.4 retool/L, P=0. 15) had no significant difference between two groups. Multiple logistic regression showed that after the body mass index (BMI) adjusted, the testosterone, LH/FSH, DHT, DHEA, and DHEA-S, leptin and IGF-1 showed to be the independent risk factor for PCOS, but not to be for hyperinsulinemia in patients with PCOS. Conclusion The leptin and IGF-1 may contribute to the pathogenesis of PCOS, but the relationship between leptin, IGF-1 and hyperinsulinemia needs more researches to confirm.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2006年第6期882-885,共4页 Journal of Sichuan University(Medical Sciences)
基金 四川省人事厅学术和技术带头人培养基金(批准号川人4200309)资助
关键词 多囊卵巢综合征 胰岛素 瘦素 胰岛素样生长因子 Polycystic ovary syndrome Insulin Leptin Insulin-like growth factor
  • 相关文献

参考文献8

  • 1Gennarelli G,Holte J,Wide L,et al.Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome? Hum Reprod,1998;13(3):535-541.
  • 2Janeckova R.The role of leptin in human physiology and pathophysiology.Physiol Res,2001;50(5):443-459.
  • 3Orabi H,Ghalia AA,Khalifa A,et al.Serum leptin as an additional possible pathogenic factor in polycystic ovary syndrome.Clin Biochem,1999;32(1):71-75.
  • 4蒋彦.卵巢内调节因子与多囊卵巢综合征[J].国外医学(妇幼保健分册),2003,14(2):104-107. 被引量:9
  • 5梁晓燕,庄广伦,方群,姚书忠.胰岛素与类胰岛素生长因子 1 对多囊卵巢综合征患者雄激素产生的作用[J].中华医学杂志,1997,77(4):266-269. 被引量:8
  • 6Kowalska I,Kinalski M,Straczkowski M,et al.Insulin,leptin,IGF-Ⅰ and insulin-dependent protein concentrations after insulin-sensitizing therapy in obese women with polycystic ovary syndrome.European Journal of Endocrinology,2001;144(5):509-515.
  • 7Zachow RJ,Magoffin DA.Direct intraovarian effects of leptin:impairment of the synergistic action of insulin-like growth factor-Ⅰ on follicle-stimulating hormone-dependent estradiol-17 beta production by rat ovarian granulosa cells.Endocrinology,1997;138(2):847-850.
  • 8Agarwal SK,Vogel K,Weitsman SR,et al.Leptin antagonizes the insulin-like growth factor-Ⅰ augmentation of steroidogenesis in granulosa and theca cells of the human ovary.J Clin Endocrinol Metab,1999;84(3):1072-1076.

二级参考文献21

  • 1[1]Wang HS, Chard T. IGFs and IGF-binding Proteins in the regulation of human ovarian and endometrial function[J]. J Endocrinol, 1999,16(1): 1 - 13.
  • 2[2]Burren CP, Wilson EM, Hwa V, et al. Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/NovH), an additional member of the IGFBP Superfamily[J]. J Clin Endocrinol Metab, 1999,84(3): 1096 - 1103.
  • 3[3]Thierry HJ, Lee PD, Faessen G, et al. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome [ J ]. J Clin Endocrinol Metab, 1999,84(9) :3030 - 3035.
  • 4[4]Leo V, Marca A, Morgante G, et al. Clomiphene citrate increases insulin-like growth factor binding protein1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome[ J ]. Hum Reprod, 2000, 15 (11): 2302 -2305.
  • 5[5]Vicenzo DL, Antonio LM, Raoul O, et al. Effect of metformin on insulin-like growth factor (IGF) I and IGF-binding protein I in polycystic ovary syndrome[J].J Clin Endocrinol Metab,2000,85(6) :1598 - 1600.
  • 6[6]Sindelka G, Cibula D, Fanta M, et al. Can hormonal contraceptives affect plasma levels of IGF-1 and IGFBP-1 in slim women with polycystic ovary syndrome [J]? Cas Lek Cesk,2001,140(15) :469 -472.
  • 7[7]Giudice LC. Growth factor action on ovarian function in polycystic ovary syndrome [ J ]. Endocrinol Metab Clin North Am, 1999,28(2) :325 - 339.
  • 8[8]Aquino CP, Hernandez VM, Hicks GJJ, et al. The role of insulin-like growth factor in polycystic ovary syndrome[J]. Ginecol Obstet Mex, 1999,67: 267 - 271.
  • 9[9]Cataldo NA. Insulin-like growth factor binding pro- teins: do they play a role in polycystic ovary syndrome [J]? Semin Reprod Endocrinol, 1997,15(2): 123 - 136.
  • 10[10]Homburg R. Involvement of growth factors in the pathophysiology of polycystic ovary syndrome [ J ]. Gynecol Endocrinol, 1998,12(6): 391-397.

共引文献15

同被引文献27

  • 1YongWU,Jing-pingOU-YANG,KeWU,YaWANG,Yun-fengZHOU,Chong-yuanWEN.Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B[J].Acta Pharmacologica Sinica,2005,26(3):345-352. 被引量:59
  • 2周丽蓉,俞瑾.补肾阴药治疗高胰岛素高雄激素无排卵症的临床观察[J].中国中西医结合杂志,1996,16(9):515-518. 被引量:107
  • 3郭鲁闽,董俊华,张景,刘志宏.特发性性早熟女性患儿血清IGF-1及瘦素检测的临床意义[J].山东医药,2007,47(10):44-45. 被引量:5
  • 4范林霄,郝敏.多囊卵巢综合征患者血清瘦素胰岛素水平的临床研究[J].山西医药杂志,2007,36(7):586-588. 被引量:4
  • 5Burghen GA,Givens JR,Kitabchi AE.Correlation of hyperandorogenism with hyperinsu1inism in polycystic ovarian disease.Clin Endocrinol Metab,1980,50:113-116.
  • 6Atamer A,Demir B,Bayhan G,et al.Serum levels of leptin and homocysteine in women with polycystic ovary syndrome and its relationship to endocrine,clinical and metabolic parameters.J Int Med Res,2008,36:96-105.
  • 7The Rotterdam ESHRE/ASRM-Sponsored PCOS Workshop Group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.Fertil Steril,2004,81:19-25.
  • 8Artini PG,di Berardino OM,Simi G,et al.Best methods for identification and treatment of PCOS.Minerva Ginecol,2010,62:33-48.
  • 9Amin AF,Abdela DE,Darwish AM,et al.Evaluation of the impact of laparoscopic ovarian drilling on Doppler indices of ovarian stromal blood,serum vascular endorhelial growth factor,and insulin-like growth factor-I in women with polycystic ovary syndrome.Fertil Steril,2003,79:938-941.
  • 10Liang FJ,Wu XK,Qu JW,et al.Response of IGF and IL-6 to ovarian stimulation in PCOS and normal women.Syst Biol Reprod Med,2009,55:227-235.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部